Abstract
Adequate drug penetration to a site of infection is absolutely imperative to ensure sufficient antimicrobial treatment. Microdialysis is a minimally invasive, versatile technique, which can be used to study the penetration of an antiinfective agent in virtually any tissue of interest. It has been used to investigate drug distribution and pharmacokinetics in variable patient populations, as a tool in dose optimization, a potential utility in therapeutic drug management, and in the study of biomarkers of disease progression. While all of these applications have not been fully explored in the field of antiinfectives, this review provides an overview of how microdialysis has been applied in various phases of drug development, a focus on the specific applications in the subspecialties of infectious disease (treatment of bacterial, fungal, viral, parasitic, and mycobacterial infections), and developing applications (biomarkers and therapeutic drug management).
Similar content being viewed by others
References
Chaurasia CS, Müller M, Bashaw ED, Benfeldt E, Bolinder J, Bullock R, et al. AAPS-FDA workshop white paper: microdialysis principles, application and regulatory perspectives. Pharm Res. 2007;24(5):1014–25.
Mindermann T, Zimmerli W, Gratzl O. Rifampin concentrations in various compartments of the human brain: a novel method for determining drug levels in the cerebral extracellular space. Antimicrob Agents Chemother. 1998;42(10):2626–9.
Kempker RR, Barth AB, Vashakidze S, Nikolaishvili K, Sabulua I, Tukvadze N, et al. Cavitary penetration of levofloxacin among patients with multidrug-resistant tuberculosis. Antimicrob Agents Chemother. 2015;59(6):3149–55.
Traunmüller F, Schintler MV, Spendel S, Popovic M, Mauric O, Scharnagl E, et al. Linezolid concentrations in infected soft tissue and bone following repetitive doses in diabetic patients with bacterial foot infections. Int J Antimicrob Agents. 2010;36(1):84–6.
Burkhardt O, Brunner M, Schmidt S, Grant M, Tang Y, Derendorf H. Penetration of ertapenem into skeletal muscle and subcutaneous adipose tissue in healthy volunteers measured by in vivo microdialysis. J Antimicrob Chemother. 2006;58(3):632–6.
Müller M. Monitoring tissue drug levels by clinical microdialysis. Altern Lab Anim. 2009;37 Suppl 1:57–9.
Schmidt S, Banks R, Kumar V, Rand KH, Derendorf H. Clinical microdialysis in skin and soft tissues: an update. J Clin Pharmacol. 2008;48(3):351–64.
Schroepf S, Burau D, Muench H-G, Derendorf H, Adam D, Kloft C. Microdialysis for therapeutic drug monitoring in infants. In: Poster abstract presented at: 8th International Symposium on Microdialysis. Uppsala, Sweden; 2016.
Deitchman AN, Derendorf H. Measuring drug distribution in the critically ill patient. Adv Drug Deliv Rev. 2014;77.
Plock N, Kloft C. Microdialysis—theoretical background and recent implementation in applied life-sciences. Eur J Pharm Sci. 2005;25(1):1–24.
MacVane SH, Housman ST, Nicolau DP. In vitro microdialysis membrane efficiency of broad-spectrum antibiotics in combination and alone. Clin Pharmacol. 2014;6:97–101.
Mukker JK, Singh RP, Derendorf H. Determination of atypical nonlinear plasma–protein-binding behavior of tigecycline using an in vitro microdialysis technique. J Pharm Sci. 2014;103(3):1013–9.
US Food and Drug Administration. Guidance for Industry: Antiviral Product Development—Conducting and Submitting Virology Studies to the Agency. 2006.
US Food and Drug Administration. Guidance for Industry: Microbiology Data for Systemic Antibacterial Drugs—Development, Analysis, and Presentation. 2016.
Schmidt S, Röck K, Sahre M, Burkhardt O, Brunner M, Lobmeyer MT, et al. Effect of protein binding on the pharmacological activity of highly bound antibiotics. Antimicrob Agents Chemother. 2008;52(11):3994–4000.
De La Peña A, Liu P, Derendorf H. Microdialysis in peripheral tissues. Adv Drug Deliv Rev. 2000:189–216.
Dhanani J, Roberts JA, Chew M, Lipman J, Boots RJ, Paterson DL, et al. Antimicrobial chemotherapy and lung microdialysis: a review. Int J Antimicrob Agents. 2010;36(6):491–500.
Notkina N, Dahyot-Fizelier C, Gupta AK. In vivo microdialysis in pharmacological studies of antibacterial agents in the brain. Br J Anaesth. 2012;109(2):155–60.
Bue M, Birke-Sørensen H, Thillemann TM, Hardlei TF, Søballe K, Tøttrup M. Single-dose pharmacokinetics of vancomycin in porcine cancellous and cortical bone determined by microdialysis. Int J Antimicrob Agents. 2015;46(4):434–8.
Hurtado KF, Laureano JV, de A Lock G, Derendorf H, Dalla Costa T. Enhanced penetration of moxifloxacin into rat prostate tissue evidenced by microdialysis. Int J Antimicrob Agents. 2014;44(4):327–33.
Cheung BWY, Liu W, Ji P, Cartier LL, Li Z, Mostafa N, et al. The chinchilla microdialysis model for the study of antibiotic distribution to middle ear fluid. AAPS J. 2006;8(1):E41–7.
de Araújo BV, Laureano JV, Grünspan LD, Dalla Costa T, Tasso L. Validation of an efficient LC-microdialysis method for gemifloxacin quantitation in lung, kidney and liver of rats. J Chromatogr B Analyt Technol Biomed Life Sci. 2013;919–920:62–6.
Macha S, Mitra AK. Ocular pharmacokinetics of cephalosporins using microdialysis. J Ocul Pharmacol Ther. 2001;17(5):485–98.
Chang Y-L, Chiou S-H, Chou Y-C, Yen C-J, Tsai T-H. Quantitative determination of unbound cefoperazone in rat bile using microdialysis and liquid chromatography. J Pharm Biomed Anal. 2007;45(1):158–63.
Sammeta SM, Vaka SRK, Murthy SN. Dermal drug levels of antibiotic (cephalexin) determined by electroporation and transcutaneous sampling (ETS) technique. J Pharm Sci. 2009;98(8):2677–85.
Tsai TH. Pharmacokinetics of pefloxacin and its interaction with cyclosporin A, a P-glycoprotein modulator, in rat blood, brain and bile, using simultaneous microdialysis. Br J Pharmacol. 2001;132(6):1310–6.
Hosoya K, Makihara A, Tsujikawa Y, Yoneyama D, Mori S, Terasaki T, et al. Roles of inner blood-retinal barrier organic anion transporter 3 in the vitreous/retina-to-blood efflux transport of p-aminohippuric acid, benzylpenicillin, and 6-mercaptopurine. J Pharmacol Exp Ther. 2009;329(1):87–93.
Xin H-L, He X-R, Li W, Zhou Z-D, Zhang S, Wang G-J. The effect of borneol on the concentration of meropenem in rat brain and blood. J Asian Nat Prod Res. 2014;16(6):648–57.
Gao W, Kishida T, Kageyama M, Kimura K, Yoshikawa Y, Shibata N, et al. Hepatic and intestinal contributions to pharmacokinetic interaction of indinavir with amprenavir, nelfinavir and saquinavir in rats. Antivir Chem Chemother. 2002;13(1):17–26.
Waga J, Ehinger B. Intravitreal concentrations of some drugs administered with microdialysis. Acta Ophthalmol Scand. 1997;75(1):36–40.
Liu P, Derendorf H. Antimicrobial tissue concentrations. Infect Dis Clin N Am. 2003;17(3):599–613.
Joukhadar C, Derendorf H, Müller M. Microdialysis: a novel tool for clinical studies of anti-infective agents. Eur J Clin Pharmacol. 2001;57(3):211–9.
Schwameis R, Zeitlinger M. Methods to measure target site penetration of antibiotics in critically ill patients. Curr Clin Pharmacol. 2013;8(1):46–58.
Shannon RJ, Carpenter KLH, Guilfoyle MR, Helmy A, Hutchinson PJ. Cerebral microdialysis in clinical studies of drugs: pharmacokinetic applications. J Pharmacokinet Pharmacodyn. 2013;40(3):343–58.
Traunmüller F, Schintler MV, Metzler J, Spendel S, Mauric O, Popovic M, et al. Soft tissue and bone penetration abilities of daptomycin in diabetic patients with bacterial foot infections. J Antimicrob Chemother. 2010;65(6):1252–7.
Schintler MV, Traunmüller F, Metzler J, Kreuzwirt G, Spendel S, Mauric O, et al. High fosfomycin concentrations in bone and peripheral soft tissue in diabetic patients presenting with bacterial foot infection. J Antimicrob Chemother. 2009;64(3):574–8.
Himebauch AS, Nicolson SC, Sisko M, Moorthy G, Fuller S, Gaynor JW, et al. Skeletal muscle and plasma concentrations of cefazolin during cardiac surgery in infants. J Thorac Cardiovasc Surg. 2014;148(6):2634–41.
Langer O, Karch R, Müller U, Dobrozemsky G, Abrahim A, Zeitlinger M, et al. Combined PET and microdialysis for in vivo assessment of intracellular drug pharmacokinetics in humans. J Nucl Med. 2005;46(11):1835–41.
Liu P, Müller M, Derendorf H. Rational dosing of antibiotics: the use of plasma concentrations versus tissue concentrations. Int J Antimicrob Agents. 2002:285–90.
Schmidt S, Barbour A, Sahre M, Rand KH, Derendorf H. PK/PD: new insights for antibacterial and antiviral applications. Curr Opin Pharmacol. 2008;8(5):549–56.
Brunner M, Derendorf H, Müller M. Microdialysis for in vivo pharmacokinetic/pharmacodynamic characterization of anti-infective drugs. Curr Opin Pharmacol. 2005:495–9.
Barbour AM, Schmidt S, Zhuang L, Rand K, Derendorf H. Application of pharmacokinetic/pharmacodynamic modelling and simulation for the prediction of target attainment of ceftobiprole against meticillin-resistant Staphylococcus aureus using minimum inhibitory concentration and time-kill curve based approaches. Int J Antimicrob Agents. Elsevier B.V.; 2014;43(1):60–7.
Bartek J, Thelin EP, Ghatan PH, Glimaker M, Bellander B-M. Neuron-specific enolase is correlated to compromised cerebral metabolism in patients suffering from acute bacterial meningitis. An observational cohort study. PLoS ONE. 2016;11(3), e0152268.
Radolf S, Smoll N, Drenckhahn C, Dreier JP, Vajkoczy P, Sarrafzadeh AS. Cerebral lactate correlates with early onset pneumonia after aneurysmal SAH. Transl Stroke Res. 2014;5(2):278–85.
Schlenk F, Frieler K, Nagel A, Vajkoczy P, Sarrafzadeh AS. Cerebral microdialysis for detection of bacterial meningitis in aneurysmal subarachnoid hemorrhage patients: a cohort study. Crit Care. 2009;13(1):R2.
Poulsen FR, Schulz M, Jacobsen A, Andersen ÅB, Larsen L, Schalén W, et al. Bedside evaluation of cerebral energy metabolism in severe community-acquired bacterial meningitis. Neurocrit Care. 2015;22(2):221–8.
Zeitlinger M, Müller M, Joukhadar C. Lung microdialysis—a powerful tool for the determination of exogenous and endogenous compounds in the lower respiratory tract (mini-review). AAPS J. 2005;7(3):E600–8.
Schuck EL, Grant M, Derendorf H. Effect of simulated microgravity on the disposition and tissue penetration of ciprofloxacin in healthy volunteers. J Clin Pharmacol. 2005;45(7):822–31.
Dalley AJ, Lipman J, Deans R, Venkatesh B, Rudd M, Roberts MS, et al. Tissue accumulation of cephalothin in burns: a comparative study by microdialysis of subcutaneous interstitial fluid cephalothin concentrations in burn patients and healthy volunteers. Antimicrob Agents Chemother. 2009;53(1):210–5.
Joukhadar C, Frossard M, Mayer BX, Brunner M, Klein N, Siostrzonek P, et al. Impaired target site penetration of beta-lactams may account for therapeutic failure in patients with septic shock. Crit Care Med. 2001;29(2):385–91.
Roberts JA, Kirkpatrick CMJ, Roberts MS, Robertson TA, Dalley AJ, Lipman J. Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution. J Antimicrob Chemother. 2009;64(1):142–50.
Brunner M, Stabeta H, Möller J-G, Schrolnberger C, Erovic B, Hollenstein U, et al. Target site concentrations of ciprofloxacin after single intravenous and oral doses. Antimicrob Agents Chemother. 2002;46(12):3724–30.
de la Pena A, Brunner M, Eichler H, Rehak E, Gross J, Thyroff-Friesinger U, et al. Comparative target site pharmacokinetics of immediate and modified-release formulations of cefaclor in humans. J Clin Pharmacol. 2002;42:403–11.
Raney SG, Franz TJ, Lehman PA, Lionberger R, Chen M-L. Pharmacokinetics-based approaches for bioequivalence evaluation of topical dermatological drug products. Clin Pharmacokinet. 2015;54(11):1095–106.
Incecayir T, Agabeyoglu I, Derici U, Sindel S. Assessment of topical bioequivalence using dermal microdialysis and tape stripping methods. Pharm Res. 2011;28(9):2165–75.
Brill MJE, Houwink API, Schmidt S, Van Dongen EPA, Hazebroek EJ, van Ramshorst B, et al. Reduced subcutaneous tissue distribution of cefazolin in morbidly obese versus non-obese patients determined using clinical microdialysis. J Antimicrob Chemother. 2014;69(3):715–23.
Barbour A, Schmidt S, Rout WR, Ben-David K, Burkhardt O, Derendorf H. Soft tissue penetration of cefuroxime determined by clinical microdialysis in morbidly obese patients undergoing abdominal surgery. Int J Antimicrob Agents. 2009;34(3):231–5.
Varghese JM, Jarrett P, Wallis SC, Boots RJ, Kirkpatrick CMJ, Lipman J, et al. Are interstitial fluid concentrations of meropenem equivalent to plasma concentrations in critically ill patients receiving continuous renal replacement therapy? J Antimicrob Chemother. 2015;70(2):528–33.
Ray A, Malin D, Nicolau DP, Wiskirchen DE. Antibiotic tissue penetration in diabetic foot infections a review of the microdialysis literature and needs for future research. J Am Podiatr Med Assoc. 2015;105(6):520–31.
Boyadjiev I, Boulamery A, Simon N, Martin C, Bruguerolle B, Leone M. Penetration of ertapenem into muscle measured by in vivo microdialysis in mechanically ventilated patients. Antimicrob Agents Chemother. 2011;55(7):3573–5.
Karjagin J, Lefeuvre S, Oselin K, Kipper K, Marchand S, Tikkerberi A, et al. Pharmacokinetics of meropenem determined by microdialysis in the peritoneal fluid of patients with severe peritonitis associated with septic shock. Clin Pharmacol Ther. 2008;83(3):452–9.
Barbour A, Schmidt S, Sabarinath SN, Grant M, Seubert C, Skee D, et al. Soft-tissue penetration of ceftobiprole in healthy volunteers determined by in vivo microdialysis. Antimicrob Agents Chemother. 2009;53(7):2773–6.
Hollenstein U, Brunner M, Mayer BX, Delacher S, Erovic B, Eichler HG, et al. Target site concentrations after continuous infusion and bolus injection of cefpirome to healthy volunteers. Clin Pharmacol Ther. 2000;67(3):229–36.
Enting RH, Hoetelmans RM, Lange JM, Burger DM, Beijnen JH, Portegies P. Antiretroviral drugs and the central nervous system. AIDS. 1998;12(15):1941–55.
Boddu SHS, Gunda S, Earla R, Mitra AK. Ocular microdialysis: a continuous sampling technique to study pharmacokinetics and pharmacodynamics in the eye. Bioanalysis. 2010;2(3):487–507.
Klimowicz A, Farfał S, Bielecka-Grzela S. Evaluation of skin penetration of topically applied drugs in humans by cutaneous microdialysis: acyclovir vs. salicylic acid. J Clin Pharm Ther. 2007;32(2):143–8.
Morgan CJ, Renwick AG, Friedmann PS. The role of stratum corneum and dermal microvascular perfusion in penetration and tissue levels of water-soluble drugs investigated by microdialysis. Br J Dermatol. 2003;148(3):434–43.
Borg N, Götharson E, Benfeldt E, Groth L, Ståhle L. Distribution to the skin of penciclovir after oral famciclovir administration in healthy volunteers: comparison of the suction blister technique and cutaneous microdialysis. Acta Derm Venereol. 1999;79(4):274–7.
Farfal S, Klimowicz A, Bielecka-Grzela S. Acyclovir concentrations in the skin of humans after a single oral dose assessed by in vivo cutaneous microdialysis. Skin Res Technol. 2006;12(4):228–34.
Simmel F, Kloft C. Microdialysis feasibility investigations with the non-hydrophilic antifungal voriconazole for potential applications in nonclinical and clinical settings. Int J Clin Pharmacol Ther. 2010;48(11):695–704.
Tre ES, Patel C, Aghara S, Yadav C, Stagni G. Optimization of perfusate pH to improve microdialysis recovery of lipophilic compounds. J Pharmacol Toxicol Methods. 66(3):276–80.
Sinnollareddy MG, Roberts MS, Lipman J, Peake SL, Roberts JA. Influence of sustained low-efficiency diafiltration (SLED-f) on interstitial fluid concentrations of fluconazole in a critically ill patient: use of microdialysis. Int J Antimicrob Agents. 2015;46(1):121–4.
Sinnollareddy MG, Roberts MS, Lipman J, Lassig-Smith M, Starr T, Robertson T, et al. In vivo microdialysis to determine subcutaneous interstitial fluid penetration and pharmacokinetics of fluconazole in intensive care unit patients with sepsis. Antimicrob Agents Chemother. 2016;60(2):827–32.
Sasongko L, Williams KM, Day RO, McLachlan AJ. Human subcutaneous tissue distribution of fluconazole: comparison of microdialysis and suction blister techniques. Br J Clin Pharmacol. 2003;56(5):551–61.
Simmel F, Kirbs C, Erdogan Z, Lackner E, Zeitlinger M, Kloft C. Pilot investigation on long-term subcutaneous microdialysis: proof of principle in humans. AAPS J. 2013;15(1):95–103.
Sun N, Xie Y, Sheng C, Cao Y, Zhang W, Chen H, et al. In vivo pharmacokinetics and in vitro antifungal activity of iodiconazole, a new triazole, determined by microdialysis sampling. Int J Antimicrob Agents. 2013;41(3):229–35.
Mathy F-X, Ntivunwa D, Verbeeck RK, Préat V. Fluconazole distribution in rat dermis following intravenous and topical application: a microdialysis study. J Pharm Sci. 2005;94(4):770–80.
Azeredo FJ, de Araújo BV, Haas SE, Torres B, Pigatto M, de Andrade C, et al. Comparison of fluconazole renal penetration levels in healthy and Candida albicans-infected Wistar rats. Antimicrob Agents Chemother. 2012;56(11):5852–7.
de Araujo BV, da Silva CF, Haas SE, Dalla Costa T. Free renal levels of voriconazole determined by microdialysis in healthy and Candida sp.-infected Wistar rats. Int J Antimicrob Agents. 2009;33(2):154–9.
Yang H, Wang Q, Elmquist WF. Fluconazole distribution to the brain: a crossover study in freely-moving rats using in vivo microdialysis. Pharm Res. 1996;13(10):1570–5.
Gratieri T, Gelfuso GM, de Freitas O, Rocha EM, Lopez RFV. Enhancing and sustaining the topical ocular delivery of fluconazole using chitosan solution and poloxamer/chitosan in situ forming gel. Eur J Pharm Biopharm Off J Arbeitsgemeinschaft für Pharm Verfahrenstechnik eV. 2011;79(2):320–7.
Mauric O, Thallinger C, Kugler SA, Joukhadar SM, Kovar FM, Konz KH, et al. The ability of fluconazole to penetrate into ventilated, healthy and inflamed lung tissue in a model of severe sepsis in rats. Pharmacology. 2011;87(3–4):130–4.
Joukhadar C, Thallinger C, Pöppl W, Kovar F, Konz KH, Joukhadar SM, et al. Concentrations of voriconazole in healthy and inflamed lung in rats. Antimicrob Agents Chemother. 2009;53(6):2684–6.
Saunte DM, Simmel F, Frimodt-Moller N, Stolle LB, Svejgaard EL, Haedersdal M, et al. In vivo efficacy and pharmacokinetics of voriconazole in an animal model of dermatophytosis. Antimicrob Agents Chemother. 2007;51(9):3317–21.
Kempker R, Heinrichs M, Vashakidze S, Nikolaishvili K, Sabulua I, Tukvadze N, et al. Lung tissue concentrations of pyrazinamide among patients with tuberculosis. In: 9th International Workshop on Clinical Pharmacology of Tuberculosis Drugs. Liverpool, United Kingdom; 2016.
Voelkner N, Voelkner A, Kima P, Derendorf H. Dose optimization of pyrazinamide based on dermal microdialysis in Wistar rats for cutaneous leishmaniasis treatment. In: Poster abstract presented at: 8th International Symposium on Microdialysis. Uppsala, Sweden; 2016.
David CN, Frias ES, Szu JI, Vieira PA, Hubbard JA, Lovelace J, et al. GLT-1-dependent disruption of CNS glutamate homeostasis and neuronal function by the protozoan parasite Toxoplasma gondii. PLoS Pathog. 2016;12(6):e1005643.
Brazís P, Barandica L, García F, Clough GF, Church MK, Puigdemont A. Dermal microdialysis in the dog: in vivo assessment of the effect of cyclosporin A on cutaneous histamine and prostaglandin D2 release. Vet Dermatol. 2006;17(3):169–74.
Romarís F, Iglesias R, García LO, Leiro J, Santamarina MT, Paniagua E, et al. Free and bound biotin molecules in helminths: a source of artifacts for avidin biotin-based immunoassays. Parasitol Res. 1996;82(7):617–22.
Caljon G, Caveliers V, Lahoutte T, Stijlemans B, Ghassabeh GH, Van Den Abbeele J, et al. Using microdialysis to analyse the passage of monovalent nanobodies through the blood–brain barrier. Br J Pharmacol. 2012;165(7):2341–53.
Jadhav S, Khaowroongrueng V, Derendorf H. Microdialysis of large molecules. J Pharm Sci, Accept Manuscr. 2016.
Kirbs C. Development and application of an in vitro and in vivo microdialysis methods contributing to biomarker profiling and characterisation of drug distribution processes. 2015.
Dragatin C, Polus F, Bodenlenz M, Calonder C, Aigner B, Tiffner KI, et al. Secukinumab distributes into dermal interstitial fluid of psoriasis patients as demonstrated by open flow microperfusion. Exp Dermatol. 2016;25(2):157–9.
Jadhav SB, Khaowroongrueng V, Fueth M, Richter W, Ottender M, Derendorf H. In vitro microdialysis of a monoclonal antibody. In: Abstract presented at 8th International Symposium on Microdialysis. Uppsala, Sweden; 2016.
Morrison C. Antibacterial antibodies gain traction. Nat Rev Drug Discov. 2015;14(11):737–8.
Herkner H, Müller MRM, Kreischitz N, Mayer BX, Frossard M, Joukhadar C, et al. Closed-chest microdialysis to measure antibiotic penetration into human lung tissue. Am J Respir Crit Care Med. 2002;165(2):273–6.
Roberts JA, Abdul-Aziz MH, Lipman J, Mouton JW, Vinks AA, Felton TW, et al. Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions. Lancet Infect Dis. 2014;14(6):498–509.
Wicha SG, Kees MG, Solms A, Minichmayr IK, Kratzer A, Kloft C. TDMx: a novel web-based open-access support tool for optimising antimicrobial dosing regimens in clinical routine. Int J Antimicrob Agents. 2015;45(4):442–4.
Schaeftlein A, Minichmayr IK, Kloft C. Population pharmacokinetics meets microdialysis: benefits, pitfalls and necessities of new analysis approaches for human microdialysis data. Eur J Pharm Sci. 2014;57:68–73.
US Food and Drug Administration. In Vitro Companion Diagnostic Devices: Guidance for Industry and Food and Drug Administration Staff. 2014.
Acknowledgements
A.N.D. would like to thank the American Foundation for Pharmaceutical Education for their support through the Pre-Doctoral Fellowship in Pharmaceutical Sciences.
Author information
Authors and Affiliations
Corresponding author
Additional information
Guest Editors: Robert E. Stratford, Nimita Dave, and Richard F. Bergstrom
Rights and permissions
About this article
Cite this article
Deitchman, A.N., Heinrichs, M.T., Khaowroongrueng, V. et al. Utility of Microdialysis in Infectious Disease Drug Development and Dose Optimization. AAPS J 19, 334–342 (2017). https://doi.org/10.1208/s12248-016-0020-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1208/s12248-016-0020-1